archives
Shedding light on 'silent killers'
Submitted by admin on Thu, 2006-04-06 08:00.... thrombosis, caused when a clot forms in the body, dislodges and then travels to the lungs, often leading to a fatal pulmonary embolism.
That figure represents more deaths from both breast cancer ...
ARIXTRA(R) Significantly Reduced Major Bleeding Compared to ...
Submitted by admin on Thu, 2006-04-06 14:00.... ARIXTRA(R) Significantly Reduced Major Bleeding Compared to LOVENOX(R) in a Study of Patients With Acute Coronary Syndromes
Issuers of news releases and not PR Newswire are solely responsible f ...
Chromos signs agreement with AppTec to manufacture multiple ...
Submitted by admin on Thu, 2006-04-06 14:00.... Chromos signs agreement with AppTec to manufacture multiple sclerosis drug candidate for toxicology studies and clinical trial using ACE System
Issuers of news releases and not PR Newswire are ...
Mutation in blood stem cells provides clues to cancer development
Submitted by admin on Thu, 2006-04-06 22:00.... thrombosis, in part related to the increased viscosity of the blood. The disorder can also lead to scarring of the bone marrow and acute leukemia. Currently, patients are treated by bleeding them (phl ...
Antithrombotic ArixtraŽ (Fondaparinux) Saves More Lives Than ...
Submitted by admin on Fri, 2006-04-07 00:00.... Antithrombotic ArixtraŽ (Fondaparinux) Saves More Lives Than Standard Therapy In People With Acute Coronary Syndrome
Patients from across 41 countries in the OASIS 5 study (Organization to Asse ...
JAK2 Mutation in blood stem cells provides clues to polycythemia ...
Submitted by admin on Fri, 2006-04-07 00:00.... thrombosis, in part related to the increased viscosity of the blood. The disorder can also lead to scarring of the bone marrow and acute leukemia. Currently, patients are treated by bleeding them (phl ...
The Medicines Company advances thrombosis therapy
Submitted by admin on Fri, 2006-04-07 02:00.... thrombosis therapy - Pharmaceutical Business Review ...